HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

China flag China · Delayed Price · Currency is CNY
3.620
+0.010 (0.28%)
Apr 29, 2026, 3:04 PM CST
44.80%
Market Cap 8.07B
Revenue (ttm) 2.12B
Net Income (ttm) 411.58M
Shares Out 2.23B
EPS (ttm) 0.18
PE Ratio 19.59
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 65,261,531
Average Volume 181,964,451
Open 3.610
Previous Close 3.610
Day's Range 3.530 - 3.660
52-Week Range 2.400 - 4.080
Beta 0.24
RSI 49.90
Earnings Date Apr 28, 2026

About SHE:002437

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 2,703
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002437
Full Company Profile

Financial Performance

In 2025, SHE:002437's revenue was 2.14 billion, a decrease of -12.51% compared to the previous year's 2.44 billion. Earnings were 376.91 million, an increase of 61.93%.

Financial Statements

News

There is no news available yet.